Seysara

Seysara is the only FDA-approved narrow-spectrum oral antibiotic intended for treatment of facial and trunk acne. It shows visible improvement in 3 weeks, reduces 50% of inflammatory lesions by week 12 and shows limited activity on beneficial gut bacteria while presenting low tendency for antibiotic resistance, photosensitivity, GI effects and vestibular effects.